Sequencing:Article Title: Frog Skin Peptides: Nature's Dual-Action Weapons Against Infection and Cancer.
Article Snippet: .. Peptide Name and Sequence Frog Species Hydrophobic Residues (%) a 3D Structure a AC Activity AB Activity Ref. Frenatin 2.1S GLVGTLLGHIGKAILG Sphaenorhynchus lacteus 50 Helix A549 (LC50 80–140 μM) 4T1 (n.d.) S. aureus ATCC 25293 (MIC 8 μM) MRSA 127/08, 145/08, 274/08, S908, T4/6, V4180 clinical isolates (MIC 8–16 μM) S. epidermidis RP62A biofilm producer, RP62A/1 biofilm non-producer variant of RP62A, T6/19 and T37/8 clinical isolates (MIC 8–16 μM) E. coli ATCC 25726 (MIC 125 μM) K. pneumoniae ATCC 700603 (MIC 250 μM) P. aeruginosa ATCC 27853 (MIC 250 μM) E. faecalis ATCC 29212 (MIC 62.5 μM) A. baumannii NM8, NM35, NM75, NM109, NM124 clinical isolates (MIC 62.5–125 μM) S. maltophilia B32/1, B32/4, B5/5, B6/2, U8708 clinical isolates (MIC 31.3–62.5 μM) X. axonopodis pv. vesicatoria (MIC 3.1–6.2 μM) * [103,104] Frenatin 2.2S GLVGTLLGHIGKAILS Sphaenorhynchus lacteus 50 Helix A549 (LC50 65 μM) S. aureus ATCC 25293 (MIC 16 μM) MRSA 127/08, 145/08, 274/08, S908, T4/6, V4180 clinical isolates (MIC 8–16 μM) S. epidermidis RP62A biofilm producer, RP62A/1 biofilm non-producer variant of RP62A, T6/19 and T37/8 clinical isolates (MIC 8–16 μM) A. baumannii NM8, NM35, NM75, NM109, NM124 clinical isolates (MIC 62.5–125 μM) S. maltophilia B32/1, B32/4, B5/5, B6/2, U8708 clinical isolates (MIC 31.3–62.5 μM) E. coli ATCC 25726 (MIC 125 μM) K. pneumoniae ATCC 700603 (MIC 250 μM) P. aeruginosa ATCC 27853 (MIC 250 μM) E. faecalis ATCC 29212 (MIC 62.5 μM) X. axonopodis pv. vesicatoria (MIC 6.2–12.5 μM) * X. arboricola pv. pruni (MIC 6.2–12.5 μM) * [103] Hylin PL FLGLIPALAGAIGNLIK Boana platanera 65 Helix A549 (LC50 58 μg/mL) HT-29 (LC50 68 μg/mL) MDA-MB-231 (LC50 58 μg/mL) E. coli DSM 787 (MIC 100 μg/mL) S. aureus ATCC 43300 (MIC 100 μg/mL) S. epidermidis DSM 28319 (MIC > 100 μg/mL) P. aeruginosa DSM 50071 (MIC > 100 μg/mL) K. pneumoniae ATCC BAA1705 (MIC > 100 μg/mL) A. baumannii DSM 30008 (MIC 100 μg/mL) E. faecalis MF 06036 (MIC 100 μg/mL) E. faecium NCTC 12201 (MIC 50 μg/mL) C. difficile R20291 or 630 BAA1382 (MIC 25–50 μg/mL) [102] https://doi.org/10.3390/antibiotics15030324 Table 1. ..
Article Title: Frog Skin Peptides: Nature's Dual-Action Weapons Against Infection and Cancer.
Article Snippet: .. Peptide Name and Sequence Frog Species Hydrophobic Residues (%) a 3D Structure a AC Activity AB Activity Ref. Temporin-1CEb ILPILSLIGGLLGK Rana chensinensis also known as amurin-3 from Rana amurensis 57 Helix A549 (n.d.) Bcap-37 (n.d.) BEL7402 (n.d.) BGC-823 (n.d.) H446 (n.d.) HeLa (n.d.) HO-8910 (n.d.) HT-29 (n.d.) LK-2 (n.d.) MCF-7 (n.d.) MDA-MB-231 (n.d.) SMMC7721 (n.d.) S. aureus ATCC 22401 (MIC 41 μM) E. coli ATCC 44102 (MIC > 100 μM) B. cereus (MIC 41 μM) * S. lactis (MIC 41 μM) * [144,145] Temporin-1Oc FLPLLASLFSRLF.NH2 Rana ornativentris 69 Helix 4T1 (LC50 65 μM)HeLa (LC50 50 μM) S. aureus NCTC 8325 (MIC 2 μM) S. aureus USA 300 (MIC 1.6 μM) S. epidermidis 1457 (MIC 1.6 μM) B. subtilis 168 (MIC 12.5 μM) E. coli ATCC 25922 (MIC > 150 μM) K. pneumoniae ATCC 13883 (MIC > 50 μM) * P. aeruginosa PAO1 (MIC > 50 μM) [146,147] Temporin-1RNb FLPLKKLRFGLL.NH2 Rana nigromaculata 58 Helix HeLa (LC50 12.8 μM)MCF-7 (LC50 11.4 μM) S. aureus AS1.72 (MIC 3.13 μM) E. coli AS1.349 (MIC 12.5 μM) P. aeruginosa (MIC 12.5 μM) * B. cereus (MIC 3.13 μM) * S. lactis (MIC 3.13 μM) * [96] Temporin-La LLRHVVKILEKYL.NH2 Lithobates catesbeianus 53 Helix BEL7402 (LC50 2.670 μg/mL) HeLa (LC50 4.685 μg/mL) MGC803 (LC50 3.937 μg/mL) SGC7901 (LC50 2.755 μg/mL) SMMC7721 (LC50 1.384 μg/mL) E. coli ATCC 25922 (MIC > 100 μg/mL) Salmonella ATCC 20020 (MIC 15.6 μg/mL) P. aeruginosa ATCC 227853 (MIC 60 μg/mL) K. pneumoniae ATCC 700603 (MIC > 100 μg/mL) S. aureus ATCC 25923 (MIC 2.5 μg/mL) S. suis type 2 CVCC 606 (MIC 15.6 μg/mL) [126,148] Temporin-PE FLPIVAKLLSGLL.NH2 Pelophylax kl. esculentus (formerly Rana esculenta) 69 Helix H157 (LC50 34.56 μM) MDA-MB-435S (LC50 33.23 μM) PC-3 (LC50 38.56 μM) U251MG (LC50 25.13 μM) S. aureus NCTC 10788 (MIC 2 μM) MRSA NCTC 12493 (MIC 4 μM) E. faecalis NCTC 12697 (MIC 8 μM) E. coli NCTC 10418 (MIC 16 μM) P. aeruginosa ATCC 27853 (MIC 128 μM) [149] https://doi.org/10.3390/antibiotics15030324 Table 1. ..
Activity Assay:Article Title: Frog Skin Peptides: Nature's Dual-Action Weapons Against Infection and Cancer.
Article Snippet: .. Peptide Name and Sequence Frog Species Hydrophobic Residues (%) a 3D Structure a AC Activity AB Activity Ref. Frenatin 2.1S GLVGTLLGHIGKAILG Sphaenorhynchus lacteus 50 Helix A549 (LC50 80–140 μM) 4T1 (n.d.) S. aureus ATCC 25293 (MIC 8 μM) MRSA 127/08, 145/08, 274/08, S908, T4/6, V4180 clinical isolates (MIC 8–16 μM) S. epidermidis RP62A biofilm producer, RP62A/1 biofilm non-producer variant of RP62A, T6/19 and T37/8 clinical isolates (MIC 8–16 μM) E. coli ATCC 25726 (MIC 125 μM) K. pneumoniae ATCC 700603 (MIC 250 μM) P. aeruginosa ATCC 27853 (MIC 250 μM) E. faecalis ATCC 29212 (MIC 62.5 μM) A. baumannii NM8, NM35, NM75, NM109, NM124 clinical isolates (MIC 62.5–125 μM) S. maltophilia B32/1, B32/4, B5/5, B6/2, U8708 clinical isolates (MIC 31.3–62.5 μM) X. axonopodis pv. vesicatoria (MIC 3.1–6.2 μM) * [103,104] Frenatin 2.2S GLVGTLLGHIGKAILS Sphaenorhynchus lacteus 50 Helix A549 (LC50 65 μM) S. aureus ATCC 25293 (MIC 16 μM) MRSA 127/08, 145/08, 274/08, S908, T4/6, V4180 clinical isolates (MIC 8–16 μM) S. epidermidis RP62A biofilm producer, RP62A/1 biofilm non-producer variant of RP62A, T6/19 and T37/8 clinical isolates (MIC 8–16 μM) A. baumannii NM8, NM35, NM75, NM109, NM124 clinical isolates (MIC 62.5–125 μM) S. maltophilia B32/1, B32/4, B5/5, B6/2, U8708 clinical isolates (MIC 31.3–62.5 μM) E. coli ATCC 25726 (MIC 125 μM) K. pneumoniae ATCC 700603 (MIC 250 μM) P. aeruginosa ATCC 27853 (MIC 250 μM) E. faecalis ATCC 29212 (MIC 62.5 μM) X. axonopodis pv. vesicatoria (MIC 6.2–12.5 μM) * X. arboricola pv. pruni (MIC 6.2–12.5 μM) * [103] Hylin PL FLGLIPALAGAIGNLIK Boana platanera 65 Helix A549 (LC50 58 μg/mL) HT-29 (LC50 68 μg/mL) MDA-MB-231 (LC50 58 μg/mL) E. coli DSM 787 (MIC 100 μg/mL) S. aureus ATCC 43300 (MIC 100 μg/mL) S. epidermidis DSM 28319 (MIC > 100 μg/mL) P. aeruginosa DSM 50071 (MIC > 100 μg/mL) K. pneumoniae ATCC BAA1705 (MIC > 100 μg/mL) A. baumannii DSM 30008 (MIC 100 μg/mL) E. faecalis MF 06036 (MIC 100 μg/mL) E. faecium NCTC 12201 (MIC 50 μg/mL) C. difficile R20291 or 630 BAA1382 (MIC 25–50 μg/mL) [102] https://doi.org/10.3390/antibiotics15030324 Table 1. ..
Article Title: Frog Skin Peptides: Nature's Dual-Action Weapons Against Infection and Cancer.
Article Snippet: .. Peptide Name and Sequence Frog Species Hydrophobic Residues (%) a 3D Structure a AC Activity AB Activity Ref. Temporin-1CEb ILPILSLIGGLLGK Rana chensinensis also known as amurin-3 from Rana amurensis 57 Helix A549 (n.d.) Bcap-37 (n.d.) BEL7402 (n.d.) BGC-823 (n.d.) H446 (n.d.) HeLa (n.d.) HO-8910 (n.d.) HT-29 (n.d.) LK-2 (n.d.) MCF-7 (n.d.) MDA-MB-231 (n.d.) SMMC7721 (n.d.) S. aureus ATCC 22401 (MIC 41 μM) E. coli ATCC 44102 (MIC > 100 μM) B. cereus (MIC 41 μM) * S. lactis (MIC 41 μM) * [144,145] Temporin-1Oc FLPLLASLFSRLF.NH2 Rana ornativentris 69 Helix 4T1 (LC50 65 μM)HeLa (LC50 50 μM) S. aureus NCTC 8325 (MIC 2 μM) S. aureus USA 300 (MIC 1.6 μM) S. epidermidis 1457 (MIC 1.6 μM) B. subtilis 168 (MIC 12.5 μM) E. coli ATCC 25922 (MIC > 150 μM) K. pneumoniae ATCC 13883 (MIC > 50 μM) * P. aeruginosa PAO1 (MIC > 50 μM) [146,147] Temporin-1RNb FLPLKKLRFGLL.NH2 Rana nigromaculata 58 Helix HeLa (LC50 12.8 μM)MCF-7 (LC50 11.4 μM) S. aureus AS1.72 (MIC 3.13 μM) E. coli AS1.349 (MIC 12.5 μM) P. aeruginosa (MIC 12.5 μM) * B. cereus (MIC 3.13 μM) * S. lactis (MIC 3.13 μM) * [96] Temporin-La LLRHVVKILEKYL.NH2 Lithobates catesbeianus 53 Helix BEL7402 (LC50 2.670 μg/mL) HeLa (LC50 4.685 μg/mL) MGC803 (LC50 3.937 μg/mL) SGC7901 (LC50 2.755 μg/mL) SMMC7721 (LC50 1.384 μg/mL) E. coli ATCC 25922 (MIC > 100 μg/mL) Salmonella ATCC 20020 (MIC 15.6 μg/mL) P. aeruginosa ATCC 227853 (MIC 60 μg/mL) K. pneumoniae ATCC 700603 (MIC > 100 μg/mL) S. aureus ATCC 25923 (MIC 2.5 μg/mL) S. suis type 2 CVCC 606 (MIC 15.6 μg/mL) [126,148] Temporin-PE FLPIVAKLLSGLL.NH2 Pelophylax kl. esculentus (formerly Rana esculenta) 69 Helix H157 (LC50 34.56 μM) MDA-MB-435S (LC50 33.23 μM) PC-3 (LC50 38.56 μM) U251MG (LC50 25.13 μM) S. aureus NCTC 10788 (MIC 2 μM) MRSA NCTC 12493 (MIC 4 μM) E. faecalis NCTC 12697 (MIC 8 μM) E. coli NCTC 10418 (MIC 16 μM) P. aeruginosa ATCC 27853 (MIC 128 μM) [149] https://doi.org/10.3390/antibiotics15030324 Table 1. ..
Variant Assay:Article Title: Frog Skin Peptides: Nature's Dual-Action Weapons Against Infection and Cancer.
Article Snippet: .. Peptide Name and Sequence Frog Species Hydrophobic Residues (%) a 3D Structure a AC Activity AB Activity Ref. Frenatin 2.1S GLVGTLLGHIGKAILG Sphaenorhynchus lacteus 50 Helix A549 (LC50 80–140 μM) 4T1 (n.d.) S. aureus ATCC 25293 (MIC 8 μM) MRSA 127/08, 145/08, 274/08, S908, T4/6, V4180 clinical isolates (MIC 8–16 μM) S. epidermidis RP62A biofilm producer, RP62A/1 biofilm non-producer variant of RP62A, T6/19 and T37/8 clinical isolates (MIC 8–16 μM) E. coli ATCC 25726 (MIC 125 μM) K. pneumoniae ATCC 700603 (MIC 250 μM) P. aeruginosa ATCC 27853 (MIC 250 μM) E. faecalis ATCC 29212 (MIC 62.5 μM) A. baumannii NM8, NM35, NM75, NM109, NM124 clinical isolates (MIC 62.5–125 μM) S. maltophilia B32/1, B32/4, B5/5, B6/2, U8708 clinical isolates (MIC 31.3–62.5 μM) X. axonopodis pv. vesicatoria (MIC 3.1–6.2 μM) * [103,104] Frenatin 2.2S GLVGTLLGHIGKAILS Sphaenorhynchus lacteus 50 Helix A549 (LC50 65 μM) S. aureus ATCC 25293 (MIC 16 μM) MRSA 127/08, 145/08, 274/08, S908, T4/6, V4180 clinical isolates (MIC 8–16 μM) S. epidermidis RP62A biofilm producer, RP62A/1 biofilm non-producer variant of RP62A, T6/19 and T37/8 clinical isolates (MIC 8–16 μM) A. baumannii NM8, NM35, NM75, NM109, NM124 clinical isolates (MIC 62.5–125 μM) S. maltophilia B32/1, B32/4, B5/5, B6/2, U8708 clinical isolates (MIC 31.3–62.5 μM) E. coli ATCC 25726 (MIC 125 μM) K. pneumoniae ATCC 700603 (MIC 250 μM) P. aeruginosa ATCC 27853 (MIC 250 μM) E. faecalis ATCC 29212 (MIC 62.5 μM) X. axonopodis pv. vesicatoria (MIC 6.2–12.5 μM) * X. arboricola pv. pruni (MIC 6.2–12.5 μM) * [103] Hylin PL FLGLIPALAGAIGNLIK Boana platanera 65 Helix A549 (LC50 58 μg/mL) HT-29 (LC50 68 μg/mL) MDA-MB-231 (LC50 58 μg/mL) E. coli DSM 787 (MIC 100 μg/mL) S. aureus ATCC 43300 (MIC 100 μg/mL) S. epidermidis DSM 28319 (MIC > 100 μg/mL) P. aeruginosa DSM 50071 (MIC > 100 μg/mL) K. pneumoniae ATCC BAA1705 (MIC > 100 μg/mL) A. baumannii DSM 30008 (MIC 100 μg/mL) E. faecalis MF 06036 (MIC 100 μg/mL) E. faecium NCTC 12201 (MIC 50 μg/mL) C. difficile R20291 or 630 BAA1382 (MIC 25–50 μg/mL) [102] https://doi.org/10.3390/antibiotics15030324 Table 1. ..
Multiple Displacement Amplification:Article Title: Frog Skin Peptides: Nature's Dual-Action Weapons Against Infection and Cancer.
Article Snippet: .. Peptide Name and Sequence Frog Species Hydrophobic Residues (%) a 3D Structure a AC Activity AB Activity Ref. Frenatin 2.1S GLVGTLLGHIGKAILG Sphaenorhynchus lacteus 50 Helix A549 (LC50 80–140 μM) 4T1 (n.d.) S. aureus ATCC 25293 (MIC 8 μM) MRSA 127/08, 145/08, 274/08, S908, T4/6, V4180 clinical isolates (MIC 8–16 μM) S. epidermidis RP62A biofilm producer, RP62A/1 biofilm non-producer variant of RP62A, T6/19 and T37/8 clinical isolates (MIC 8–16 μM) E. coli ATCC 25726 (MIC 125 μM) K. pneumoniae ATCC 700603 (MIC 250 μM) P. aeruginosa ATCC 27853 (MIC 250 μM) E. faecalis ATCC 29212 (MIC 62.5 μM) A. baumannii NM8, NM35, NM75, NM109, NM124 clinical isolates (MIC 62.5–125 μM) S. maltophilia B32/1, B32/4, B5/5, B6/2, U8708 clinical isolates (MIC 31.3–62.5 μM) X. axonopodis pv. vesicatoria (MIC 3.1–6.2 μM) * [103,104] Frenatin 2.2S GLVGTLLGHIGKAILS Sphaenorhynchus lacteus 50 Helix A549 (LC50 65 μM) S. aureus ATCC 25293 (MIC 16 μM) MRSA 127/08, 145/08, 274/08, S908, T4/6, V4180 clinical isolates (MIC 8–16 μM) S. epidermidis RP62A biofilm producer, RP62A/1 biofilm non-producer variant of RP62A, T6/19 and T37/8 clinical isolates (MIC 8–16 μM) A. baumannii NM8, NM35, NM75, NM109, NM124 clinical isolates (MIC 62.5–125 μM) S. maltophilia B32/1, B32/4, B5/5, B6/2, U8708 clinical isolates (MIC 31.3–62.5 μM) E. coli ATCC 25726 (MIC 125 μM) K. pneumoniae ATCC 700603 (MIC 250 μM) P. aeruginosa ATCC 27853 (MIC 250 μM) E. faecalis ATCC 29212 (MIC 62.5 μM) X. axonopodis pv. vesicatoria (MIC 6.2–12.5 μM) * X. arboricola pv. pruni (MIC 6.2–12.5 μM) * [103] Hylin PL FLGLIPALAGAIGNLIK Boana platanera 65 Helix A549 (LC50 58 μg/mL) HT-29 (LC50 68 μg/mL) MDA-MB-231 (LC50 58 μg/mL) E. coli DSM 787 (MIC 100 μg/mL) S. aureus ATCC 43300 (MIC 100 μg/mL) S. epidermidis DSM 28319 (MIC > 100 μg/mL) P. aeruginosa DSM 50071 (MIC > 100 μg/mL) K. pneumoniae ATCC BAA1705 (MIC > 100 μg/mL) A. baumannii DSM 30008 (MIC 100 μg/mL) E. faecalis MF 06036 (MIC 100 μg/mL) E. faecium NCTC 12201 (MIC 50 μg/mL) C. difficile R20291 or 630 BAA1382 (MIC 25–50 μg/mL) [102] https://doi.org/10.3390/antibiotics15030324 Table 1. ..
Article Title: Frog Skin Peptides: Nature's Dual-Action Weapons Against Infection and Cancer.
Article Snippet: .. Peptide Name and Sequence Frog Species Hydrophobic Residues (%) a 3D Structure a AC Activity AB Activity Ref. Temporin-1CEb ILPILSLIGGLLGK Rana chensinensis also known as amurin-3 from Rana amurensis 57 Helix A549 (n.d.) Bcap-37 (n.d.) BEL7402 (n.d.) BGC-823 (n.d.) H446 (n.d.) HeLa (n.d.) HO-8910 (n.d.) HT-29 (n.d.) LK-2 (n.d.) MCF-7 (n.d.) MDA-MB-231 (n.d.) SMMC7721 (n.d.) S. aureus ATCC 22401 (MIC 41 μM) E. coli ATCC 44102 (MIC > 100 μM) B. cereus (MIC 41 μM) * S. lactis (MIC 41 μM) * [144,145] Temporin-1Oc FLPLLASLFSRLF.NH2 Rana ornativentris 69 Helix 4T1 (LC50 65 μM)HeLa (LC50 50 μM) S. aureus NCTC 8325 (MIC 2 μM) S. aureus USA 300 (MIC 1.6 μM) S. epidermidis 1457 (MIC 1.6 μM) B. subtilis 168 (MIC 12.5 μM) E. coli ATCC 25922 (MIC > 150 μM) K. pneumoniae ATCC 13883 (MIC > 50 μM) * P. aeruginosa PAO1 (MIC > 50 μM) [146,147] Temporin-1RNb FLPLKKLRFGLL.NH2 Rana nigromaculata 58 Helix HeLa (LC50 12.8 μM)MCF-7 (LC50 11.4 μM) S. aureus AS1.72 (MIC 3.13 μM) E. coli AS1.349 (MIC 12.5 μM) P. aeruginosa (MIC 12.5 μM) * B. cereus (MIC 3.13 μM) * S. lactis (MIC 3.13 μM) * [96] Temporin-La LLRHVVKILEKYL.NH2 Lithobates catesbeianus 53 Helix BEL7402 (LC50 2.670 μg/mL) HeLa (LC50 4.685 μg/mL) MGC803 (LC50 3.937 μg/mL) SGC7901 (LC50 2.755 μg/mL) SMMC7721 (LC50 1.384 μg/mL) E. coli ATCC 25922 (MIC > 100 μg/mL) Salmonella ATCC 20020 (MIC 15.6 μg/mL) P. aeruginosa ATCC 227853 (MIC 60 μg/mL) K. pneumoniae ATCC 700603 (MIC > 100 μg/mL) S. aureus ATCC 25923 (MIC 2.5 μg/mL) S. suis type 2 CVCC 606 (MIC 15.6 μg/mL) [126,148] Temporin-PE FLPIVAKLLSGLL.NH2 Pelophylax kl. esculentus (formerly Rana esculenta) 69 Helix H157 (LC50 34.56 μM) MDA-MB-435S (LC50 33.23 μM) PC-3 (LC50 38.56 μM) U251MG (LC50 25.13 μM) S. aureus NCTC 10788 (MIC 2 μM) MRSA NCTC 12493 (MIC 4 μM) E. faecalis NCTC 12697 (MIC 8 μM) E. coli NCTC 10418 (MIC 16 μM) P. aeruginosa ATCC 27853 (MIC 128 μM) [149] https://doi.org/10.3390/antibiotics15030324 Table 1. ..
other:
|